Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A Pfizer logo is displayed at a research facility in the La Jolla neighborhood of San Diego, California, U.S., ...

A patient died after receiving Pfizer Inc.’s drug for hemophilia, marking another setback for the company in the treatment of blood disorders. The death occurred on Dec. 14 after the patient ...

A patient who was being treated with Pfizer’s PFE.N hemophilia drug, Hympavzi, as part of a long-term study died after experiencing serious side effects, the company said. The individual died on ...